• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision regarding whether or not to stop taking strattera adhd medication medication during pregnancy and breast-feeding. There are few data regarding how exposure over time may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental conditions like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must consider the benefits of taking it versus the risks for the fetus. Doctors don't have the information needed to make unequivocal recommendations, but they can provide information about the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the study had its limitations. Most important, they were unable to distinguish the effects of the medication from the effects of the disorder at hand. This makes it difficult for researchers to determine if the small associations observed among the groups exposed were due to the use of medication or affected by comorbidities. In addition, the researchers did not examine the long-term outcomes of offspring.

The study revealed that infants whose mothers had taken ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. The reason for this was central nervous system-related disorders and the higher risk of admission did not appear to be affected by the type of stimulant medications were taken during pregnancy.

Women who took stimulant safest adhd medication For adults medications used to treat adhd during pregnancy also had a higher risk of having to have a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies may be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, when possible, help them develop strategies for improving their coping skills that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the issue of whether to keep or stop treatment during pregnancy is a question that more and more doctors face. These decisions are often made without clear and authoritative evidence. Instead, doctors have to consider their own expertise in conjunction with the experiences of other physicians and the research that has been conducted on the subject.

The issue of risk to the infant can be particularly tricky. The research that has been conducted on this topic is based on observations rather than controlled studies and a lot of the results are in conflict. Additionally, the majority of studies limit their analysis to live births, which may undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion is that while some studies have found a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slightly negative effect. In the end, a careful risk/benefit assessment must be done in each situation.

It can be challenging, if not impossible, for women suffering from ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for patients with ADHD. In addition, a decrease in medication can affect the ability to do work-related tasks and safely drive which are essential aspects of daily life for many people with ADHD.

She suggests women who are uncertain about whether to keep or stop taking medication because of their pregnancy should consider educating family members, friends and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment regimen. It can also make the woman feel more comfortable in her struggle with her decision. Certain medications can adhd medication help with memory be passed through the placenta. If a patient decides not to take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use and use of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the potential adverse effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. Researchers used two massive data sets to study over 4.3 million pregnant women and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to ADHD medications was associated with an increased risk of certain heart defects, like ventriculo-septal defects (VSD).

The authors of the study did not find any association between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are in line with previous studies that have shown an increase, but not significant, in the risk of developing cardiac malformations in women who started taking ADHD medications before the time of pregnancy. The risk was higher in the later part of pregnancy, as many women decide to stop taking their ADHD medications.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who needed help breathing at birth. The authors of the study were unable to remove bias in selection since they limited their study to women with no other medical conditions that might have contributed to the findings.

Researchers hope their research will help doctors when they see pregnant women. The researchers recommend that while discussing the risks and benefits are crucial, the decision on whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and her needs.

The authors also warn that, while stopping the medication is an option, it isn't an option to consider due to the high rate of depression and other mental health problems among women who are pregnant or recently post-partum. Furthermore, research suggests that women who choose to stop their medications are more likely to experience difficulties adapting to life without them following the baby's arrival.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments, getting ready for the arrival of their child and adapting to new routines in the home can experience severe challenges. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk at a low estrogen and adhd medication level. The amount of exposure to medications will differ based on dosage the medication is administered, its frequency and time of day. In addition, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn is not completely comprehended.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the patient, who must weigh the benefits of keeping her medication against the possible risks to the foetus. Until more information becomes available, doctors may inquire about pregnant patients if they have a background of ADHD or if they intend to take medication in the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely while breastfeeding and during pregnancy. This has led to more and more patients choose to do so, and in consultation with their physician, they have found that the benefits of keeping their current medication exceed any risk.

It's important for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder and learn about treatments and to reinforce existing strategies for managing. This should involve a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if necessary modifications to the medication regimen.